Index Company
Novo Nordisk
2 CÈ pieces since 11 May 2026: 2 essays. Newest first. All companies →
-
Semaglutide slowed four epigenetic clocks in a randomised trial, and left a fifth unmoved
A 32-week randomised trial moved DunedinPACE, PhenoAge and two GrimAge clocks on weekly semaglutide; the Intrinsic Capacity clock, built to track how well a body still works, did not shift.
-
Novo Nordisk handed OpenAI its full operation. Singapore's contract labs are next.
Novo Nordisk's deal with OpenAI is being read as a drug-discovery story. The part that resets Singapore's biotech cluster is the supply chain, the manufacturing schedule, and the corporate operation.